Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012
- PMID: 29769908
- PMCID: PMC5868630
- DOI: 10.14745/ccdr.v40is3a02
Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012
Abstract
Background: To describe the adverse event following immunization (AEFI) reporting profile for vaccines administered in Canada during 2012 and surveillance trends relative to reports for vaccines administered from 2005 through 2011.
Methods: Analysis of data based on AEFI reports received by the Public Health Agency of Canada by April 30, 2013, for vaccines marketed in Canada and administered from January 1, 2005, through December 31, 2012.
Results: The AEFI reporting rate was 10.1 per 100,000 population in Canada for vaccines administered in 2012 and was inversely proportional to age. There was a trend of declining rates from 2005 (14.8) to 2012 overall and by age group. The vast majority of reports (94%-95%) were non-serious involving reactions at or near the vaccination site, rash and febrile events.
Conclusion: Canada has a strong pharmacovigilance system for vaccines with one of the highest AEFI reporting rates in developed countries. Vaccines marketed in Canada have a very good safety profile. This report enables comparisons across jurisdictions in Canada and globally.
Conflict of interest statement
Conflict of interest: None
Figures
Similar articles
-
Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017.Can Commun Dis Rep. 2018 Dec 6;44(12):324-330. doi: 10.14745/ccdr.v44i12a04. eCollection 2018 Dec 6. Can Commun Dis Rep. 2018. PMID: 31517950 Free PMC article.
-
Vaccine safety surveillance in Canada: Reports to CAEFISS, 2013-2016.Can Commun Dis Rep. 2018 Sep 6;44(9):206-214. doi: 10.14745/ccdr.v44i09a04. eCollection 2018 Sep 6. Can Commun Dis Rep. 2018. PMID: 31015811 Free PMC article.
-
Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.Vaccine. 2013 Nov 19;31(48):5700-5. doi: 10.1016/j.vaccine.2013.09.048. Epub 2013 Oct 5. Vaccine. 2013. PMID: 24099871
-
Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.Indian J Pediatr. 2018 Feb;85(2):139-148. doi: 10.1007/s12098-017-2532-9. Epub 2017 Nov 23. Indian J Pediatr. 2018. PMID: 29170922 Review.
-
Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.Vaccine. 2013 Jan 11;31(4):603-17. doi: 10.1016/j.vaccine.2012.11.051. Epub 2012 Nov 29. Vaccine. 2013. PMID: 23200940 Review.
Cited by 11 articles
-
Interpretation of vaccine associated neurological adverse events: a methodological and historical review.J Neurol. 2022 Jan;269(1):493-503. doi: 10.1007/s00415-021-10747-8. Epub 2021 Aug 16. J Neurol. 2022. PMID: 34398270 Free PMC article. Review.
-
Assessing safety of Ontario's publicly funded MMR and MMRV immunization programs, 2012 to 2016.Paediatr Child Health. 2019 Apr 8;25(6):358-364. doi: 10.1093/pch/pxz037. eCollection 2020 Oct. Paediatr Child Health. 2019. PMID: 32963648 Free PMC article.
-
Retrospective study of immunization errors reported in an online Information System.Rev Lat Am Enfermagem. 2020 Jun 19;28:e3303. doi: 10.1590/1518-8345.3343.3303. eCollection 2020. Rev Lat Am Enfermagem. 2020. PMID: 32578753 Free PMC article.
-
Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community-Spain (2008-2018).Vaccines (Basel). 2020 Mar 2;8(1):117. doi: 10.3390/vaccines8010117. Vaccines (Basel). 2020. PMID: 32131535 Free PMC article.
-
Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017.Can Commun Dis Rep. 2018 Dec 6;44(12):324-330. doi: 10.14745/ccdr.v44i12a04. eCollection 2018 Dec 6. Can Commun Dis Rep. 2018. PMID: 31517950 Free PMC article.
LinkOut - more resources
Full Text Sources
Miscellaneous